Complejo Hospitalario Universitario Insular - Materno Infantil de Canarias-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach

    Archives of pathology & laboratory medicine, Vol. 148, Núm. 3, pp. 318-326

2021

  1. Pan-TRK immunohistochemistry an example-based practical approach to efficiently identify patients with NTRK fusion cancer

    Archives of Pathology and Laboratory Medicine, Vol. 145, Núm. 8, pp. 1031-1040

  2. Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes

    Leukemia and Lymphoma, Vol. 62, Núm. 9, pp. 2130-2140

2020

  1. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)

    Targeted Oncology, Vol. 15, Núm. 5, pp. 613-622

2019

  1. Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

    Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132

2017

  1. Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification

    Neuro-Oncology, Vol. 19, Núm. 11, pp. 1522-1531

2014

  1. Accurate identification of ALK positive lung carcinoma patients: Novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

    PLoS ONE, Vol. 9, Núm. 9

  2. Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007

    International Journal of Cancer, Vol. 135, Núm. 1, pp. 88-95

2012

  1. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention

    Gynecologic Oncology, Vol. 124, Núm. 3, pp. 512-517

2010

  1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

    The Lancet Oncology, Vol. 11, Núm. 11, pp. 1048-1056